​

Funding Round

Series A - BioIntervene

Series A - BioIntervene

Investment Firm

Overview

BioIntervene is engages in drug discovery and development.

Announced Date

Jan 06, 2020

Funding Type

Series A

Highlights

Location

United States, North America

Social

N/A

Investor Lead

MPM Capital

MPM Capital

MPM Capital is a early_stage_venture and late_stage_venture and private_equity and seed firm.

Participant Investors

1

Investor Name
Participant InvestorMPM Capital

Round Details and Background

BioIntervene raised $30000000 on 2020-01-06 in Series A

BioIntervene is engages in drug discovery and development.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 12, 2019
Venture Round - BioIntervene
-3.1M
Jan 06, 2020
Series A - BioIntervene
1-30.0M
Jun 23, 2021
Venture Round - BioIntervene
-5.6M

Recent Activity

There is no recent news or activity for this profile.